Replies to post #105395 on Biotech Values

[jq1234]

It seems like they have a bit of a vendetta against MNTA

Of course they do, because MNTA threatens Teva's Copaxone franchise. If there weren't Copaxone, Teva would not have singled out m-enox as much as they have.